Literature DB >> 16897668

Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children.

Karen L Sleeman1, David Griffiths, Fiona Shackley, Linda Diggle, Sunetra Gupta, Martin C Maiden, E Richard Moxon, Derrick W Crook, Timothy E A Peto.   

Abstract

BACKGROUND: The relative invasiveness rates (attack rates) of Streptococcus pneumoniae of different capsular serotypes in children are not known. Estimates of capsular serotype invasiveness (designated "invasive odds ratios") that are based on cross-sectional prevalence carriage data have been published, but these estimates could be biased by variation in the duration of carriage.
METHODS: The relative attack rates of invasive pneumococci were measured using national UK surveillance data on invasive pneumococcal disease (IPD) incidence and data on incidence of pneumococcal acquisition from longitudinal studies of nasopharyngeal pneumococcal carriage.
RESULTS: We found significant differences in capsular serotype-specific attack rates. For example, capsular serotypes 4, 14, 7F, 9V, and 18C were associated with rates of >20 IPD cases/100,000 acquisitions, whereas capsular serotypes 23F, 6A, 19F, 16F, 6B, and 15B/C were associated with <10 IPD cases/100,000 acquisitions. There was an inverse relationship between duration of carriage and attack rate by capsular serotype (P<.0001). Attack rates were significantly correlated with invasive odds ratios (P<.0001).
CONCLUSIONS: The capsular serotype is a major determinant of both pneumococcal duration of carriage and attack rate. Published invasive odds ratios are a reliable and practical method of determining capsular serotype invasiveness and will be valuable for investigating and characterizing emerging capsular serotypes in the context of conjugate vaccination.

Entities:  

Mesh:

Year:  2006        PMID: 16897668     DOI: 10.1086/505710

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  109 in total

1.  Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.

Authors:  Allison M Brady; Juan J Calix; Jigui Yu; Kimball Aaron Geno; Gary R Cutter; Moon H Nahm
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

Review 2.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

Review 3.  Patterns of antigenic diversity and the mechanisms that maintain them.

Authors:  Marc Lipsitch; Justin J O'Hagan
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

4.  Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing.

Authors:  Alexey V Rakov; Kimiko Ubukata; D Ashley Robinson
Journal:  Infect Genet Evol       Date:  2011-08-25       Impact factor: 3.342

Review 5.  Phenotypic Heterogeneity, a Phenomenon That May Explain Why Quorum Sensing Does Not Always Result in Truly Homogenous Cell Behavior.

Authors:  Jessica Grote; Dagmar Krysciak; Wolfgang R Streit
Journal:  Appl Environ Microbiol       Date:  2015-05-29       Impact factor: 4.792

6.  Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system.

Authors:  O Hurmic; N Grall; M Al Nakib; C Poyart; S Grondin; M-C Ploy; E Varon; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-15       Impact factor: 3.267

7.  Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.

Authors:  Alessia Melegaro; Yoon Hong Choi; Robert George; W John Edmunds; Elizabeth Miller; Nigel J Gay
Journal:  BMC Infect Dis       Date:  2010-04-08       Impact factor: 3.090

8.  Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine.

Authors:  Silvio D Brugger; Pascal Frey; Suzanne Aebi; Jason Hinds; Kathrin Mühlemann
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

9.  Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine.

Authors:  Alison S Laufer; Jonathan C Thomas; Marisol Figueira; Janneane F Gent; Stephen I Pelton; Melinda M Pettigrew
Journal:  Vaccine       Date:  2010-01-10       Impact factor: 3.641

10.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.